Preoperative chemotherapy for non-small-cell lung cancer--authors' reply
Lancet
.
2014 Jul 19;384(9939):233.
doi: 10.1016/S0140-6736(14)61209-5.
Authors
Sarah Burdett
1
,
Larysa H M Rydzewska
2
,
Jayne F Tierney
2
,
Anne Auperin
3
,
Jean-Pierre Pignon
3
,
Cécile Le Pechoux
3
,
Thierry Le Chevalier
3
,
Jan van Meerbeeck
4
Affiliations
1
MRC Clinical Trials Unit at UCL, London WC2B 6NH, UK. Electronic address: sarah.burdett@ucl.ac.uk.
2
MRC Clinical Trials Unit at UCL, London WC2B 6NH, UK.
3
Service de Biostatistique et d'Epidemiologie, Institut Gustave-Roussy, Villejuif, France.
4
University Hospital Antwerp, Antwerp, Belgium.
PMID:
25042232
DOI:
10.1016/S0140-6736(14)61209-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lung Neoplasms / drug therapy*
Male
Grants and funding
MC_U122861323/MRC_/Medical Research Council/United Kingdom